Levetiracetam Belupo

Levetiracetam, the active ingredient in Levetiracetam Belupo, is an antiepileptic presented as an oral tablet for oral use. It is prescribed to control various types of seizures in adults and children as determined by a healthcare professional.

GNH USA supplies Levetiracetam Belupo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication that reduces seizure activity across several seizure types. - Partial‑onset seizures: helps achieve seizure freedom or reduction in frequency. - Generalized tonic‑clonic seizures: contributes to control of convulsive episodes. - Myoclonic seizures: diminishes rapid, involuntary muscle jerks.

Levetiracetam may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Drowsiness: mild to moderate fatigue. - Dizziness: sensation of light‑headedness. - Headache: transient cranial discomfort. - Irritability: mood changes or agitation. - Nausea: mild gastrointestinal upset. - Nasal congestion: mild upper‑respiratory irritation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood disorders: depression or suicidal thoughts. - Blood disorders: leukopenia or thrombocytopenia. - Hepatic dysfunction: elevated liver enzymes. - Severe skin reactions: Stevens‑Johnson syndrome. - Multiorgan failure: extremely rare but life‑threatening.

Before initiating therapy, consider the following safety measures. - Renal impairment: adjust dose based on creatinine clearance. - Hepatic disease: monitor liver function tests regularly. - Psychiatric history: observe for mood changes or suicidal ideation. - Pregnancy: discuss potential risks with a healthcare provider; safety data are limited. - Breastfeeding: evaluate benefit‑risk ratio before use. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may lower levetiracetam exposure. - Phenytoin: may decrease levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: can increase central nervous system depression. - Sedatives or hypnotics: may enhance drowsiness. - Other antiepileptics: monitor seizure control and side‑effect profile.